The meeting opens with a morning programme of expert-led presentations focusing on contemporary developments in pelvic imaging and their impact on clinical practice. Faculty will share insights into evolving diagnostic approaches, highlighting the complementary roles of ultrasound, MRI, and emerging technologies in the assessment of gynaecological conditions. Sessions will also explore practical strategies for image interpretation, multidisciplinary collaboration, and the use of imaging to support effective clinical decision-making and patient management.

Throughout the morning, scheduled breaks and the lunchtime interval provide valuable opportunities for delegates to visit exhibitor stands, engage with the scientific poster exhibition, and connect with colleagues working across women’s health, imaging, and research. These informal networking moments are designed to encourage discussion, knowledge exchange, and collaboration within the multidisciplinary community.

In the afternoon, the programme transitions to a more interactive format, with delegates participating in a structured practical skills programme. These hands-on sessions are designed to reinforce key learning points from the morning presentations and provide participants with the opportunity to apply techniques, discuss real-world clinical scenarios, and further develop their imaging skills under expert guidance.

Beginner / Intermediate – ideal for those developing core skills in ultrasound image optimisation, systematic image interpretation, and recognition of common pelvic pathologies. Practical stations focus on optimising ultrasound images, identifying sonographic features of endometriosis and adenomyosis, and gaining an introductory understanding of 3D ultrasound acquisition and its clinical applications.

Advanced Clinical – designed for experienced practitioners looking to deepen their expertise in pelvic imaging and advanced ultrasound practice. Practical stations include demystifying MRI for gynaecological assessment, simulation based training in ultrasound guided fibroid ablation, strategies for artefact reduction and optimisation of image quality, and advanced simulation in ultrasound assessment of obstetric anal sphincter injuries (OASI) and rectal endometriosis to support imaging led clinical decision making.

Each track consists of four rotating practical stations, with 45 minutes dedicated to each station and a coffee break scheduled midway through the session. These small-group, hands-on sessions provide a structured opportunity to practise techniques, explore imaging findings, and discuss clinical applications with expert faculty in a supportive learning environment.

Who Should Attend?

This meeting is intended for a broad multidisciplinary audience involved and interested in women’s health imaging, diagnosis, and clinical management. It provides an opportunity for professionals working across different specialties to come together, share perspectives, and enhance their understanding of imaging in gynaecological practice.

It will be particularly relevant for:

• Gynaecologists

• Radiologists

• Sonographers

• Specialist nurses

• Fellows and trainees

• Allied health professionals with an interest in gynaecological imaging

• Researchers working in imaging and women’s health

Whether participants are building their experience in gynaecological imaging or are established practitioners seeking to update and refine their knowledge, the programme is designed to provide practical insights and clinically relevant learning that can be applied in everyday practice.

Afternoon Practical Skills Sessions  

Delegates allocated to one of two tracks: 

• Track A: Beginner / Intermediate Level 

• Track B: Advanced Clinical 

Each track has 4 practical stations with 45 minutes per station. Coffee break after two stations. 

We look forward to welcoming you in London for a day of inspiration, innovation and collaborative learning at the UK’s leading gynaecological imaging event.

Mr Anthony Griffiths – Consultant Obstetrician and Gynaecologist, University Hospital of Wales

Mr Anthony Griffiths is the President Elect of the British Society for Gynaecological Imaging and a specialist in minimal access surgery, endometriosis, and infertility. He is an accredited endometriosis surgeon with the British Society for Gynaecological Endoscopy and established the first tertiary referral endometriosis centre in Wales. He has trained numerous consultants who have gone on to lead successful endometriosis services across the UK.

His surgical expertise includes complex excision of deep endometriosis affecting the bowel, bladder, and diaphragm, nerve-sparing techniques to preserve pelvic function, and the use of advanced laparoscopic imaging technologies for enhanced precision. He routinely performs laparoscopic hysterectomies, often as day-case procedures, laparoscopic tubal surgery including sterilisation reversal, and removal of ovarian cysts and fibroids.

Mr Griffiths is recognised for his patient-centred approach, emphasising trust, clear communication, and individualised care. Known for his approachable and down-to-earth style, he ensures patients feel listened to, informed, and actively involved in decisions about their treatment, particularly for those experiencing pelvic pain, heavy periods, or fertility challenges.

He also serves as Chief Investigator on a major multinational clinical trial investigating new treatments for endometriosis, contributing to both research innovation and the advancement of clinical practice in gynaecology.

Dr James Harding – Consultant Clinical & Interventional Radiology – University Hospital Coventry & Warwickshire

Dr Harding is a Consultant in Clinical & Interventional Radiology based at University Hospital Coventry & Warwickshire (UHCW) since 2010 where he is the Clinical Lead for Interventional Radiology. He trained in Medicine at the University of Bristol and achieved membership of the Royal College of Physicians (UK) in 2004. He began training in Radiology in 2005 and achieved Fellowship of the Royal College of Radiologists in 2008 winning the Finzi prize in the Radiology section of the Royal Society of Medicine. He completed a period of higher specialist training with many of the UK’s experts in Interventional Radiology.

His daily practice includes a wide range of minimally invasive ‘pin-hole’ procedures including treatment for uterine fibroids & adenomyosis with uterine artery embolisation (UAE), angioplasty for peripheral vascular disease, transarterial chemoembolisation (TACE) for liver tumours, embolisation in men for varicocoeles and in women for pelvic venous disorders.

He has worked actively performing and promoting the new procedure of Prostate Artery Embolisation (PAE) for men with obstructive urinary symptoms, being one of the early exponents in the UK of PAE since 2013. He was heavily involved in research for this specialist technique leading one of the top five contributing centres in the national UKRoPE study, the first multi-centre research into PAE in the UK. He has subsequently been the local PI in the SPEED study into treatment for traumatic splenic bleeding and the current GEKO study, a randomised trial assessing genicular artery embolization (GAE) vs placebo for knee osterarthritis.

He is heavily involved with the British Society of Interventional Radiology being a past chair of the Audit and Registries committee, currently acting as the BSIR representative to the National Vascular Registry.

Dr Harding is leading a BSIR working group in evidencing and establishing appropriate treatment pathways for women with pelvic venous disorder (PeVD), a very common and misunderstood condition, and is working with multi-disciplinary colleagues via the Cardiovascular and Interventional Radiology Society of Europe (CIRSE) to develop a registry study treating patients with PeVD.

Mrs Leena Gokhale – Consultant Obstetrician and Gynaecologist – Aneurin Bevan Health Board Hospital

Mrs Gokhale, MBBS, MSc, FRCOG is the Immediate Past President of the British Society for Gynaecological Imaging and a Consultant Obstetrician and Gynaecologist with 23 years of clinical experience. She has served as Lead for the Gynaecology Cancer Unit and overall Gynaecology services for the past eight years.

Her specialist interests include gynaecological ultrasound, gynaecological oncology, minimal access surgery, ambulatory gynaecology services, and medical education and training. She has been recognised nationally for her contributions, receiving the “Women’s Role Model of the Year 2023” award from BAPIO and the National Clinical Impact Award in 2026.

Dr Gokhale is also an invited speaker for esteemed networks including the BSGE Ambulatory Care Network and FOGSI, reflecting her commitment to advancing clinical practice, education, and innovation in gynaecology.

Miss Lina Antoun – Consultant Gynaecologist – Birmingham Women’s & Children’s Hospital

Miss Antoun specialising in minimal access surgery. She completed her training in advanced laparoscopic surgery and colposcopy at Birmingham Women’s Hospital and was a research fellow at University of Birmingham. She has authored and co-authored peer-reviewed publications, presented both nationally and internationally on numerous occasions and received both national and international prizes at scientific meetings for her contribution and work in minimally invasive gynaecological surgery.

In 2022, she was elected as a BSGE council member responsible for the trainee’s portfolio and was re-elected in 2024 as senior council member overseeing the laparoscopic training portfolio. She continues to participate as facilitator for the RCOG/BSGE Laparoscopic training courses and works as part of the team to help deliver the successful and popular national RIGs Hub National Training Programme. She is presently the BSGE Chair of Laparoscopic Training and the Chair of Education and Training for ESGE.

She is dedicated to providing compassionate, evidence-based care for women experiencing complex gynaecological conditions. Her work bridges the gap between cutting-edge research and patient focused care, with the aim of improving outcomes and quality of life for women.  She is currently researching the application of Myoblate related to patient outcomes

Miss Ghada Salman – Consultant Gynaecologist – University College London Hospitals

Mr Dipankar Chowdhury – Consultant Obstetrician and Gynaecologist – University Hospitals Birmingham NHS Foundation Trust

Dr Adam Aboalkaz – Consultant Radiologist – Cardiff and Vale University Health Board

Angie White – Sonographer – Lecturer at Brunel University of London

Fuad Hussain – Consultant Diagnostic and Interventional Radiologist – Royal Surrey NHS Foundation Trust

KEBOMED UK is a specialist distributor of medical devices with a primary focus on minimally invasive gynaecology, urology, general surgery, and enteral devices. We approach our work with enthusiasm and a clear understanding that a patient is at the centre of everything we do.

KEBOMED UK supports its product portfolio with a direct, professional sales team covering the whole of the United Kingdom. We provide tailored, cost-effective, and innovative solutions that enable clinicians to achieve reproducible results, support the peri-operative team with a safer working environment, and ultimately improve patient outcomes.

We are also proud distributors of Myoblate, an ultrasound-guided radiofrequency ablation device for the treatment of uterine fibroids. It is a multimodal, cost-effective technology that allows clinicians to treat myomas using a minimally invasive, incision-less approach, helping to reduce both treatment and recovery times compared with more traditional surgical options.

SonoScape is a global medical technology company specialising in the design, development, and manufacture of advanced diagnostic ultrasound systems and endoscopy solutions. Founded in 2002, SonoScape has built a strong international reputation for delivering high-performance imaging, intelligent software, and outstanding value, supporting clinicians in delivering confident and efficient patient care.

With installations in over 170 countries, SonoScape serves hospitals, private clinics, community diagnostic centres, and specialist practices across a wide range of clinical applications.

Our Mission

To improve healthcare outcomes by making advanced medical imaging more accessible, without compromising on image quality, usability, or clinical performance.

THD is a global MedTech company.  We support OASI clinics with focused, clinician-friendly diagnostics. Our portable kit includes an endoanal ultrasound probe which delivers clear 360° sphincter imaging, while the Anopress (anal manometry) provides rapid, reproducible functional assessment — together enabling accurate diagnosis, baseline measurement, and effective follow-up of obstetric anal sphincter injuries.  THD are also pleased to introduce our latest offering –  endorectal ultrasound to help diagnose rectovaginal endometriosis.

Vagentle is an intimate healthcare brand backed by pharmaceutical expertise. Using high-quality ingredients and medical insight, we deliver safe, effective hygiene solutions that support women’s intimate health needs across all life stages

MIS Healthcare are committed to providing industry leading medical imaging systems and comprehensive attentive service support. Providing the highest standards of customer service and support is embedded within our everyday company values. Our Samsung Ultrasound portfolio aids clinicians to navigate even the most complex cases with confidence. Our easy-to-use systems are designed to enhance the efficiency of routine procedures, allowing healthcare providers to focus on delivering precise and compassionate care to their patients. Every solution we offer is driven by our dedication to improving patient outcomes and developing a superior healthcare experience.

At Exeltis we are dedicated to the well-being of women, we firmly believe in supporting women to be empowered to make informed choices on their health. Exeltis offers a range of products that have been developed to support women throughout the different stages of their lives. Making sure that these products improve the life quality of women is at the centre of everything that we do.

Gedeon Richter have a presence in over 100 countries worldwide and have been working to change lives for the better since 1901. We are one of the few companies in the world to offer a comprehensive portfolio for women; our R&D team continue to innovate and extend our gynaecological, fertility and osteoporosis portfolio, aiming to address women’s healthcare needs in these areas. Our ambition is to help women achieve theirs.

THEMIS Clinical Defence revolutionises healthcare indemnity with specialist, contractual protection tailored exclusively for clinical professionals and institutions. Our comprehensive policies ensure clear, non-discretionary cover, safeguarding clinicians from negligence claims and protecting hospitals with bespoke corporate indemnity. Driven by real-time claims data, competitive premiums, and expert underwriting, our service combines robust risk management with exceptional, personalised support. Backed by a dedicated Clinical Governance and Claims team, we empower practitioners to focus on patient care, confident in our secure, forward-thinking indemnity solutions.

About Bayer in Women’s Healthcare 

Bayer is committed to developing innovative treatments and, with a long heritage in Women’s Healthcare, has an ongoing commitment to offer a wide range of effective short- and long-acting contraception methods. Women have options for each life stage plus a choice of therapies for menopause management and gynaecological conditions, including relief of heavy menstrual bleeding. 

PP-PF-WHC-GB-0357                       Date of Preparation: December 2025 

Bayer has sponsored an exhibition stand

In accepting the above sponsorship, you should be aware and agree that Bayer will, in order to comply with the requirements of the ABPI Code of Practice for the Pharmaceutical Industry and other relevant codes (“the Code”) and any applicable laws from time to time in force, make public disclosures on an individual named institution basis of any payments or other transfers of value (as defined in the Code) which are made to your organisation in relation to this sponsorship (this does not apply to costs specifically for the provision of subsistence when the payment is made directly to the caterer by Bayer). Such disclosures may be made on or through a fully searchable industry (ABPI) designated platform/website and/or on Bayer websites or other media, mentioning the name, address and unique identification number of the institution.

Surgical Science is a global leader in evidence-based medical simulation. The company’s virtual reality simulators and customized training solutions enable healthcare professionals to practice and improve their skills away from clinic and theatres, enhancing patient safety and clinical outcomes.

The Bevan Commission is Wales’ leading independent health and care think tank, hosted and supported by Swansea University. Our vision is for a prudent and sustainable national health and care service that meets the needs of all citizens, both now and in the future, and remains true to the principles of Aneurin Bevan. Our mission is to challenge thinking and practice in health and care, creating a growing movement for change.    

We are Theramex, a global speciality pharmaceutical company solely committed to supporting the health needs of women through every stage of life. We work on patient-focused, effective solutions that support women of all ages. 

We work closely with our partners, healthcare professionals, and patients to provide women with the right solution, at the time they most need it. 

We believe in empowering women to make informed decisions about how to manage the natural cycles and stages of their life. To do this, we provide education and support around contraception, fertility and menopause. 

This meeting is sponsored by Theramex with the presence of an exhibition stand and promotional symposium. 

At Canon Medical, our mission is to enrich every life we touch. We are dedicated to equipping healthcare professionals with the systems, knowledge, and skills that prioritise patient wellbeing through exceptional image quality, technology, and education. Our versatile ultrasound solutions are designed to enhance productivity and support early diagnosis across a broad range of clinical areas, empowering clinicians to operate more efficiently and improve patient outcomes. 

ABSTRACT SUBMISSIONS HAVE NOW CLOSED 

The BSGI invites you to submit your abstracts for presentation at our Annual Scientific Meeting 2026, taking place at 1 Wimpole Street on Friday 19th June 2026.

The ASM is the Society’s flagship annual event, bringing together radiologists, sonographers, gynaecologists, radiographers, trainees and researchers with a shared interest in advancing gynaecological imaging. The 2026 meeting promises a stimulating scientific programme, expert led sessions, and valuable opportunities for practical training, networking and collaboration.

The poster exhibition, provides a platform to showcase high quality work from across the field. This is an exciting opportunity to present your research, innovation, and service developments, gain recognition for your work, and contribute to the continued evolution of best practice in gynaecological imaging.

We welcome submissions that highlight excellence and advancement in gynaecological and women’s imaging, including:

• Original research in gynaecological imaging

• Clinical audits and quality improvement projects within gynaecological imaging services

• Service development initiatives improving patient pathways, access, and multidisciplinary collaboration

• Innovations in imaging techniques, technology, education, and training in women’s health.

Abstracts are encouraged from professionals at all career stages, including trainees, consultants, sonographers, radiographers, researchers, and allied healthcare professionals working within the field. We particularly encourage trainee submissions as an opportunity to present work in a supportive national forum.

Submitting an abstract to ASM 2026 offers the chance to:

• Share your work with a specialist national audience

• Receive feedback from peers and leaders in the field

• Strengthen your academic and professional portfolio

• Contribute to improving standards and outcomes in women’s healthcare

We encourage early preparation to ensure your work is ready for submission.

We look forward to receiving your abstracts and welcoming you to ASM 2026 for what promises to be an inspiring and aspirational meeting dedicated to excellence in women’s health imaging.

Deadline for submissions – 17th April 2026.

Submission Guidelines